Atlas Trials

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

Clinical trial NCT01072773 · COMPLETED

Trial details

NCT number
NCT01072773
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Systemic Amyloidosis
Start date
2010-03-01
Primary completion
2011-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.